Viva Biotech Holdings
Viva Biotech Holdings, a leading player in the biotechnology sector, is headquartered in China (CN) and operates extensively across Asia and beyond. Founded in 2008, the company has established itself as a prominent provider of drug discovery services, specialising in structure-based drug design and high-throughput screening. Viva Biotech's unique offerings include its proprietary technology platforms that enhance the efficiency of drug development processes, setting it apart in a competitive market. With a strong focus on innovation, the company has achieved significant milestones, including collaborations with major pharmaceutical firms and a robust portfolio of successful projects. Recognised for its expertise and commitment to advancing biopharmaceutical research, Viva Biotech Holdings continues to solidify its position as a trusted partner in the global biotech landscape.
DitchCarbon Score
How does Viva Biotech Holdings's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Viva Biotech Holdings's score of 14 is lower than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Viva Biotech Holdings's reported carbon emissions
In 2021, Viva Biotech Holdings reported total carbon emissions of approximately 37,456,150 kg CO2e, with Scope 1 emissions accounting for about 958,111 kg CO2e and Scope 2 emissions contributing approximately 36,499,030 kg CO2e. The company has not disclosed emissions data for the years 2022 and 2023, indicating a lack of transparency in their reporting for these periods. Viva Biotech Holdings has not set any specific reduction targets or initiatives, as evidenced by the absence of documented reduction targets or commitments to the Science Based Targets initiative (SBTi). This suggests that the company may not currently be prioritising formal climate commitments or strategies to mitigate its carbon footprint. The emissions data provided does not indicate any cascaded information from a parent or related organisation, confirming that the figures are solely from Viva Biotech Holdings. Overall, the company's climate commitments and emissions reporting appear limited, highlighting an area for potential improvement in sustainability practices.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | |
|---|---|
| Scope 1 | 958,111.2 |
| Scope 2 | 36,499,030 |
| Scope 3 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Viva Biotech Holdings is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
